Angiodynamics (ANGO) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $11.24, -2.94% vs the prior close of $11.58.
- Volume 890.68K shares, 1.4x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
ANGO dips 2.9% to $11.24. Closed at $11.24, -2.94% vs the prior close of $11.58. Day range $11.06–$11.73, opened at $11.61.
ANGO daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — ANGO dips 2.9% to $11.24
- Closed at $11.24, -2.94% vs the prior close of $11.58. Day range $11.06–$11.73, opened at $11.61.
- Volume was 890.68K shares, 1.4x its 50-day average of 630.21K.
- Price is -24.7% vs its 50-day average ($14.93) and -9.6% vs its 200-day average ($12.43).
- 52-week range $9.39–$16.29; today's close sits at 27% of that range, 31.0% below the 52-week high.
Oct 15, 2026 — ANGO jumps 4.8% to $11.58 on 1.8x normal volume
- Closed at $11.58, +4.80% vs the prior close of $11.05. Day range $11.05–$11.63, opened at $11.05.
- Volume was 1.14M shares, 1.8x its 50-day average of 618.24K — unusually heavy trading.
- Price is -22.8% vs its 50-day average ($15.01) and -6.9% vs its 200-day average ($12.44).
- 52-week range $9.39–$16.29; today's close sits at 32% of that range, 28.9% below the 52-week high.
Oct 14, 2026 — ANGO rises 1.4% to $11.05 on 2.7x normal volume
- Closed at $11.05, +1.38% vs the prior close of $10.90. Day range $10.73–$11.48, opened at $10.79.
- Volume was 1.59M shares, 2.7x its 50-day average of 598.93K — unusually heavy trading.
- Price is -26.7% vs its 50-day average ($15.08) and -11.2% vs its 200-day average ($12.45).
- 52-week range $9.39–$16.29; today's close sits at 24% of that range, 32.2% below the 52-week high.
Oct 13, 2026 — ANGO slides 4.4% to $10.90, a 3-month low on 2.3x normal volume
- Closed at $10.90, -4.39% vs the prior close of $11.40. Day range $10.62–$11.52, opened at $11.43.
- Volume was 1.35M shares, 2.3x its 50-day average of 587.49K — unusually heavy trading.
- Price is -28.1% vs its 50-day average ($15.16) and -12.5% vs its 200-day average ($12.46).
- 52-week range $9.39–$16.29; today's close sits at 22% of that range, 33.1% below the 52-week high.
Oct 12, 2026 — ANGO dips 1.0% to $11.40 on 1.9x normal volume
- Closed at $11.40, -1.04% vs the prior close of $11.52. Day range $11.30–$11.71, opened at $11.42.
- Volume was 1.08M shares, 1.9x its 50-day average of 575.18K — unusually heavy trading.
- Price is -25.2% vs its 50-day average ($15.25) and -8.6% vs its 200-day average ($12.47).
- 52-week range $9.39–$16.29; today's close sits at 29% of that range, 30.0% below the 52-week high.
Oct 9, 2026 — ANGO rises 2.6% to $11.52 on 4.0x normal volume
- Closed at $11.52, +2.58% vs the prior close of $11.23. Day range $10.86–$11.97, opened at $11.12.
- Volume was 2.16M shares, 4.0x its 50-day average of 540.04K — unusually heavy trading.
- Price is -24.8% vs its 50-day average ($15.31) and -7.7% vs its 200-day average ($12.48).
- 52-week range $9.39–$16.29; today's close sits at 31% of that range, 29.3% below the 52-week high.
Oct 8, 2026 — ANGO slides 20.9% to $11.23, a 3-month low on 6.3x normal volume
- Closed at $11.23, -20.86% vs the prior close of $14.19. Day range $11.06–$13.80, opened at $13.22.
- Volume was 3.06M shares, 6.3x its 50-day average of 487.46K — unusually heavy trading.
- Price is -27.0% vs its 50-day average ($15.38) and -10.1% vs its 200-day average ($12.49).
- 52-week range $9.39–$16.29; today's close sits at 27% of that range, 31.1% below the 52-week high.
- That makes 3 straight losses.
- SEC filings that day: 10-Q, DEF 14A, 8-K, 8-K.
- This was a results day: the company filed an earnings release (8-K Item 2.02).
Oct 7, 2026 — ANGO dips 1.6% to $14.19, a 1-month low on 2.1x normal volume
- Closed at $14.19, -1.60% vs the prior close of $14.42. Day range $14.13–$14.51, opened at $14.20.
- Volume was 1.00M shares, 2.1x its 50-day average of 477.66K — unusually heavy trading.
- Price is -8.1% vs its 50-day average ($15.45) and +13.5% vs its 200-day average ($12.50).
- 52-week range $9.39–$16.29; today's close sits at 70% of that range, 12.9% below the 52-week high.
Oct 6, 2026 — ANGO slides 7.2% to $14.42, a 1-month low on 1.8x normal volume
- Closed at $14.42, -7.21% vs the prior close of $15.54. Day range $14.23–$15.66, opened at $15.61.
- Volume was 847.50K shares, 1.8x its 50-day average of 468.77K — unusually heavy trading.
- Price is -6.7% vs its 50-day average ($15.45) and +15.4% vs its 200-day average ($12.49).
- 52-week range $9.39–$16.29; today's close sits at 73% of that range, 11.5% below the 52-week high.
Oct 5, 2026 — ANGO rises 2.8% to $15.54
- Closed at $15.54, +2.85% vs the prior close of $15.11. Day range $14.92–$15.63, opened at $15.02.
- Volume was 636.20K shares, 1.4x its 50-day average of 462.70K.
- Price is +0.7% vs its 50-day average ($15.44) and +24.4% vs its 200-day average ($12.49).
- 52-week range $9.39–$16.29; today's close sits at 89% of that range, 4.6% below the 52-week high.
Oct 2, 2026 — ANGO ends flat (-0.1%) to $15.11, a 1-month low on 2.5x normal volume
- Closed at $15.11, -0.07% vs the prior close of $15.12. Day range $15.00–$15.36, opened at $15.36.
- Volume was 1.13M shares, 2.5x its 50-day average of 445.92K — unusually heavy trading.
- Price is -1.9% vs its 50-day average ($15.40) and +21.1% vs its 200-day average ($12.48).
- 52-week range $9.39–$16.29; today's close sits at 83% of that range, 7.2% below the 52-week high.
- That makes 3 straight losses.
ANGO latest news & SEC filings
Every SEC filing by or about ANGO in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 8, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Aug 31, 2026:
- Revenue: $80.92M (prior year $75.71M) (+6.9% vs Aug 31, 2025)
- Net income: -$7.10M (prior year -$10.90M) (loss narrowed vs Aug 31, 2025)
- Diluted EPS: -$0.17 (prior year -$0.26) (loss narrowed vs Aug 31, 2025)
Oct 8, 2026 · Form DEFA14A — Additional proxy materials
Additional proxy materials
Oct 8, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Oct 8, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Oct 8, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Sep 29, 2026 · Form 10-K/A — Annual report (amended)
Amended annual report
Fiscal year ended May 31, 2026:
- Net income: -$36.74M (prior year -$33.99M) (loss widened vs May 31, 2025)
Sep 29, 2026 · Form 10-K/A — Annual report (amended)
Amended annual report
Key figures from this report aren't in the SEC's structured data yet (usually appears within a day or two).
Jul 31, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Nighan Warren Jr sold 23,370 shares at $14.72 (≈$344.01K) on Jul 30, 2026
- Nighan Warren Jr sold 23,370 shares at $14.72 (≈$344.01K) on Jul 30, 2026
- Nighan Warren Jr sold 23,370 shares at $14.72 (≈$344.01K) on Jul 30, 2026
- Nighan Warren Jr sold 23,370 shares at $14.72 (≈$344.01K) on Jul 30, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jul 30, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Jul 24, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 24, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 24, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 24, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 14, 2026 · Form 10-K — Annual report
Annual report (audited full-year financial statements and business review)
Fiscal year ended May 31, 2026:
- Revenue: $320.17M (prior year $292.50M) (+9.5% vs May 31, 2025)
- Net income: -$36.74M (prior year -$33.99M) (loss widened vs May 31, 2025)
- Diluted EPS: -$0.88 (prior year -$0.83) (loss widened vs May 31, 2025)
Jul 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Things to know before you trade ANGO
- Last results release: Oct 8, 2026 (8-K Item 2.02). Previous ones: Jul 14, 2026, Apr 2, 2026, Jan 6, 2026. Based on that rhythm, the next report is likely around Jan 7, 2027 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.96% (largest 20.9%).
- Liquidity: about 999.46K shares (≈$11.23M) trade per day on average.
- 52-week position: $11.24 vs a range of $9.39–$16.29 (27% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 12 open-market buys, 4 sales; latest: Warren Jr Nighan sold 23,370 shares on Jul 30, 2026.
- Latest filings: 10-Q Oct 8, 2026; 8-K Oct 8, 2026; 8-K Oct 8, 2026.
- Share count: 42.05M shares outstanding (Oct 7, 2026), +2.1% vs a year earlier.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
ANGO market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 11.61 | 11.73 | 11.06 | 11.24 | 890.68K |
| Oct 15, 2026 | 11.05 | 11.63 | 11.05 | 11.58 | 1.14M |
| Oct 14, 2026 | 10.79 | 11.48 | 10.73 | 11.05 | 1.59M |
| Oct 13, 2026 | 11.43 | 11.52 | 10.62 | 10.90 | 1.35M |
| Oct 12, 2026 | 11.42 | 11.71 | 11.30 | 11.40 | 1.08M |
| Oct 9, 2026 | 11.12 | 11.97 | 10.86 | 11.52 | 2.16M |
| Oct 8, 2026 | 13.22 | 13.80 | 11.06 | 11.23 | 3.06M |
| Oct 7, 2026 | 14.20 | 14.51 | 14.13 | 14.19 | 1.00M |
| Oct 6, 2026 | 15.61 | 15.66 | 14.23 | 14.42 | 847.50K |
| Oct 5, 2026 | 15.02 | 15.63 | 14.92 | 15.54 | 636.20K |
| Oct 2, 2026 | 15.36 | 15.36 | 15.00 | 15.11 | 1.13M |
| Oct 1, 2026 | 15.36 | 15.52 | 14.96 | 15.12 | 685.10K |
| Sep 30, 2026 | 15.65 | 15.66 | 15.33 | 15.38 | 634.50K |
| Sep 29, 2026 | 15.54 | 15.63 | 14.89 | 15.60 | 862.10K |
| Sep 28, 2026 | 15.49 | 15.76 | 15.20 | 15.54 | 533.60K |
| Sep 25, 2026 | 15.32 | 15.65 | 15.15 | 15.49 | 635.50K |
| Sep 24, 2026 | 15.48 | 15.64 | 15.00 | 15.28 | 497.50K |
| Sep 23, 2026 | 15.66 | 15.88 | 15.23 | 15.51 | 503.40K |
| Sep 22, 2026 | 15.57 | 15.73 | 15.39 | 15.67 | 439.40K |
| Sep 21, 2026 | 15.44 | 15.50 | 15.13 | 15.42 | 315.70K |
About Angiodynamics
Angiodynamics (ANGO) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in LATHAM, NY. State of incorporation: DE. Fiscal year ends May 31. SEC CIK 1275187.
ANGO board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Eileen O'Shea Auen | Director | Jul 22, 2026 |
| Lorinda Burgess | Director | Jul 22, 2026 |
| James C Clemmer | President and CEO | Jul 24, 2026 |
| Howard W Donnelly | Director | Jul 22, 2026 |
| Wesley Johnson | Director | Jul 22, 2026 |
| Karen A Licitra | Director | Jul 22, 2026 |
| Jan Stern Reed | Director | Jul 22, 2026 |
| Michael E Tarnoff | Director | Jul 22, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Chad Thomas Campbell | SVP/GM, Vascular Access | Jul 24, 2026 |
| James C Clemmer | President and CEO | Jul 24, 2026 |
| Warren Jr Nighan | SVP Quality and Regulatory | Jul 31, 2026 |
| Laura Piccinini | SVP International | Jul 24, 2026 |
| Stephen A Trowbridge | EVP and CFO | Jul 24, 2026 |
| Lawrence T Weiss | SVP, Chief Legal Officer | Jul 22, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 30, 2026 | Warren Jr Nighan | Sale | 23,370 | $14.72 |
| Jul 30, 2026 | Warren Jr Nighan | Sale | 23,370 | $14.72 |
| Jul 30, 2026 | Warren Jr Nighan | Sale | 23,370 | $14.72 |
| Jul 30, 2026 | Warren Jr Nighan | Sale | 23,370 | $14.72 |
| Oct 21, 2025 | Lawrence T Weiss | Buy | 10,000 | $11.81 |
| Oct 21, 2025 | Lawrence T Weiss | Buy | 10,000 | $11.81 |
| Oct 21, 2025 | Lawrence T Weiss | Buy | 10,000 | $11.81 |
| Oct 21, 2025 | Lawrence T Weiss | Buy | 10,000 | $11.81 |
| Oct 13, 2025 | Stephen A Trowbridge | Buy | 890 | $11.16 |
| Oct 13, 2025 | Stephen A Trowbridge | Buy | 890 | $11.16 |
| Oct 13, 2025 | Stephen A Trowbridge | Buy | 890 | $11.16 |
| Oct 13, 2025 | Stephen A Trowbridge | Buy | 890 | $11.16 |
| Oct 9, 2025 | James C Clemmer | Buy | 10,000 | $11.15 |
| Oct 9, 2025 | James C Clemmer | Buy | 10,000 | $11.15 |
| Oct 9, 2025 | James C Clemmer | Buy | 10,000 | $11.15 |
ANGO financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| May 31, 2026 | $320.17M | $-36.74M | -0.88 | $3.09M |
| May 31, 2025 | $292.50M | $-33.99M | -0.83 | $-10.13M |
| May 31, 2024 | $303.91M | $-184.35M | -4.59 | $-28.16M |
| May 31, 2023 | $338.75M | $-52.44M | -1.33 | $78.00K |
| May 31, 2022 | $316.22M | $-26.55M | -0.68 | $-7.19M |
Latest balance sheet: total assets $241.93M, total liabilities $77.97M, cash $33.97M (as of Aug 31, 2026).
ANGO earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Oct 8, 2026 | 8-K Item 2.02 (results) | $11.23 |
| Jul 14, 2026 | 8-K Item 2.02 (results) | $13.00 |
| Apr 2, 2026 | 8-K Item 2.02 (results) | $10.31 |
| Jan 6, 2026 | 8-K Item 2.02 (results) | $11.44 |
| Oct 2, 2025 | 8-K Item 2.02 (results) | $11.74 |
| Jul 15, 2025 | 8-K Item 2.02 (results) | $8.65 |
| Apr 2, 2025 | 8-K Item 2.02 (results) | $10.86 |
| Jan 8, 2025 | 8-K Item 2.02 (results) | $12.94 |
| Oct 3, 2024 | 8-K Item 2.02 (results) | — |
| Jul 16, 2024 | 8-K Item 2.02 (results) | — |
| Jul 16, 2024 | 8-K Item 2.02 (results) | — |
| Apr 4, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on ANGO
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.